| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Patel Gautam is a Director at Amneal Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 9 sells.
Estimated insider holdings value: $23.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 94,906 | $8.02 | $761,146.12 | -5.6% | +20.7% | - | |
| Jun 10, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 56,426 | $8.02 | $452,536.52 | -3.2% | +24.6% | - | |
| May 5, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 8,668 | $8.00 | $69,344.00 | -0.3% | +5.6% | +70.2% | |
| Apr 1, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 80,000 | $8.30 | $664,000.00 | -4.4% | -1.7% | +54.4% | |
| Mar 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 80,000 | $8.90 | $712,000.00 | -4.2% | -15.3% | +52.1% | |
| Feb 3, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 80,000 | $8.14 | $651,200.00 | -4.1% | -7.8% | +74.2% | |
| Jan 8, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 62,590 | $8.01 | $501,345.90 | -3.1% | -13.3% | +63.8% | |
| Jan 2, 2025 | AMRX Amneal Pharmaceuticals, Inc. | Director | Sell | 17,410 | $8.01 | $139,454.10 | -0.8% | +5.3% | +63.1% | |
| Dec 17, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Director | Buy | 50,000 | $4.21 | $210,500.00 | +23.9% | -2.8% | -47.8% | |
| Mar 3, 2020 | AMRX Amneal Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 150,000 | $3.93 | $589,073.34 | +338.4% | - | - |